Tumor necrosis factor α as a new target for renal cell carcinoma : two sequential phase II trials of infliximab at standard and high dose

Autoria(s): Harrison, Michelle L.; Obermueller, Eva; Maisey, Nick R.; Hoare, Susan; Edmonds, Kim; Li, Ningfeng F.; Chao, David; Hall, Kate; Lee, Chooi; Timotheadou, Eleni; Charles, Kellie; Ahern, Roger; King, D. Mike; Eisen, Tim; Corringham, Robert; DeWitte, Mark; Balkwill, Frances; Gore, Martin
Data(s)

01/01/2007
Identificador

http://hdl.handle.net/10536/DRO/DU:30052314
Idioma(s)

eng
Publicador

American Society of Clinical Oncology
Relação

http://dro.deakin.edu.au/eserv/DU:30052314/hall-tumornecrosis-2007.pdf

http://dx.doi.org/10.1200/JCO.2007.11.2136
Tipo

Journal Article
Acesso ao item digital